Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

The Lancet

Volumn 341, Issue 8848, 1993, Pages 788-789

  Herrero, C ^a   Vicente, A ^a   Mascaro J M ^a   Bruguera, M ^a   Barrera, J M ^a   Teres J ^a   Rodes J ^a   Ercilla, M G ^a   Vidal, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHESIS; IMMUNOBLOTTING; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMAN; IMMUNOBLOTTING; LIVER; MALE; PORPHYRIA CUTANEA TARDA; RISK FACTORS; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T;

EID: 0027468374     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)90562-U     Document Type: Article

References (10)

1. Porphyria cutanea tarda: a multifactorial disease
2. Liver involvement in porphyria
3. The pathology of the liver in porphyria cutanea tarda
4. Hepatic pathology in porphyria cutanea tarda
5. Porphyria cutanea tarda and hepatocellular carcinoma frequency of occurrence and related factors
6. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
7. The 5'-terminal sequence of the hepatitis C virus genome
8. Glutation reducido linfocitazio y hepatitis crònica activa por virus C